Evaluation of anti-CENP reactivity in samples with centromere HEp-2 pattern and correlation with Systemic Sclerosis clinical features - Keppeke, Gerson D.; Landoni, Diana; Kayser, Cristiane; Matos, Pedro; Diogenes, Larissa; Keppeke, Jessica; Rodrigues, Silvia Helena; Andrade, Luis Eduardo C. (medRxiv, 2024)
Background/Objectives Anti-centromere antibodies are associated with limited cutaneous Systemic Sclerosis (lcSSc) and in general, with a more favorable prognosis for SSc. Centromere pattern (AC-3) observed in the immunofluorescence assay in HEp-2 cells (HEp-2-IFA) suggests the presence of antibodies against CENP antigens, mainly CENP-B/A. In this study, we evaluated the frequency of reactivity to CENP-B and CENP-A in samples with an AC-3 pattern in the HEp-2-IFA. We also correlated the demographic and clinical characteristics of SSc patients according to the presence of the AC-3 pattern.Methods Samples from 39 SSc patients with AC-3 pattern were included and evaluated for CENP-B/A reactivity by line-blot and indirect ELISA. As controls, 48 lcSSc without the AC-3 pattern (Non-AC-3 group) were included. Clinical characteristics were recovered for 69 patients, 21 with AC-3 and all those in the Non-AC-3 group.Results Out of 39 samples with AC-3, 33 (84.6%) were reactive against CENP-B and 32 (82.1%) were reactive against CENP-A using the line-blot assay. Using anti-CENP-B ELISA, 36 (92.3%) of the samples with AC-3 were positive for anti-CENP-B. There was 79.5% concordance for CENP-B reactivity between ELISA and line-blot. Using the immunoblot assay, 27 (69.2%) of the samples with AC-3 were reactive against CENP-B and CENP-A, and one sample was positive only for CENP-A. Altogether, 38 samples (97.4%) were reactive against CENP-B by at least one method and all 39 samples (100%) were positive for either CENP-B or CENP-A in at least one of the tests. Regarding the clinical features, interstitial lung disease was less frequent in patients with AC-3 pattern compared to Non-AC-3 (10% versus 54.2%; p=0.001). Other organ involvement parameters had similar frequencies between the groups.Conclusions In conclusion, the HEp-2-IFA method was 100% sensitive in detecting antibodies to CENP-A and CENP-B. Anti-CENP-B is the predominant autoantibody in samples yielding the AC-3 pattern, but exclusive anti-CENP-A reactivity was observed less frequently. Among lcSSc patients, anti-centromere reactivity was associated with less frequent lung involvement.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study was funded by Sao Paulo Government agency FAPESP (Sao Paulo State Research Foundation) grant numbers #2017/20745-1 and #2021/04588-9, granted to G.D.K. and L.D. Additionally, L.E.C.A. was supported by the Brazilian research agency National Council for Research (CNPq), grant # PQ-1D 310334/2019-5.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Ethics committee of Federal University of Sao Paulo - Brazil gave ethical approval for this work (Plataforma Brasil CAAE: 59126320.1.0000.5505).I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesAll data produced in the present study are available upon reasonable request to the authors by qualified researchers.